Department of Gynecology, 477093Central Hospital of Panyu District, Shiqiao, Guangzhou, People's Republic of China.
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820942245. doi: 10.1177/1533033820942245.
Cervical cancer is a deadly disease. Some microRNAs are involved in tumor invasion and metastasis. Decreased expression of microRNA-199a has been correlated with tumorigenesis. In our study, the quantitative real-time polymerase chain reaction results indicated that microRNA-199a was expressed at lower levels in cervical cancer tissues, and the expression level of B7-H3 was significantly increased compared with that in the adjacent normal tissues, and the expression levels of B7-H3 and microRNA-199a in cervical cancer tissues and in adjacent normal tissues were inversely correlated. We also found that the expression of microRNA-199a was downregulated in cervical cancer cell lines when compared to immortalized cells. In this study, B7-H3 was identified as a novel target of microRNA-199a in cervical cancer. TargetScan (http://www.targetscan.org/) bioinformatics analysis was used to predict that the 3'-untranslated region of B7-H3 is a direct target of microRNA-199a. The result was also verified by the luciferase reporter assay. MicroRNA-199a could directly target the 3'-untranslated region of B7-H3, but the specific signaling pathways that were involved in regulating B7-H3 expression remained unclear. To clarify whether the suppressive effect of microRNA-199a was mediated through B7-H3, a series of experiments were performed. We found that the overexpression of microRNA-199a inhibited cell proliferation, migration, and invasion via direct binding to B7-H3. Epithelial-mesenchymal transition is a major factor involved in cervical cancer metastasis. Quantitative real-time polymerase chain reaction and western blot results indicated that microRNA-199a inhibits tumor progression in cervical cancer by targeting B7-H3. The microRNAs regulatory network is quite complex. We further examined the effect of microRNA-199a on the AKT/mTOR signaling pathway. We explored the regulatory role of microRNA-199a and first demonstrated that highly expressed microRNA-199a inhibits tumor growth and activates the AKT/mTOR signaling pathway by targeting B7-H3 and . Our findings not only provide a better understanding of the pathogenesis of cervical cancer but also provide novel findings and theoretical support for potential targeted therapeutic tools for cervical cancer.
宫颈癌是一种致命的疾病。一些 microRNAs 参与肿瘤的侵袭和转移。microRNA-199a 的表达降低与肿瘤发生有关。在我们的研究中,定量实时聚合酶链反应结果表明,microRNA-199a 在宫颈癌组织中表达水平较低,与相邻正常组织相比,B7-H3 的表达水平显著升高,并且宫颈癌组织和相邻正常组织中 B7-H3 和 microRNA-199a 的表达水平呈负相关。我们还发现,与永生化细胞相比,microRNA-199a 在宫颈癌细胞系中的表达下调。在这项研究中,B7-H3 被确定为宫颈癌中 microRNA-199a 的一个新靶点。TargetScan(http://www.targetscan.org/)生物信息学分析预测 B7-H3 的 3'-非翻译区是 microRNA-199a 的直接靶点。该结果也通过荧光素酶报告基因检测得到验证。microRNA-199a 可以直接靶向 B7-H3 的 3'-非翻译区,但调节 B7-H3 表达的具体信号通路尚不清楚。为了阐明 microRNA-199a 的抑制作用是否通过 B7-H3 介导,我们进行了一系列实验。我们发现,microRNA-199a 的过表达通过直接结合 B7-H3 抑制细胞增殖、迁移和侵袭。上皮-间充质转化是宫颈癌转移的一个主要因素。定量实时聚合酶链反应和 Western blot 结果表明,microRNA-199a 通过靶向 B7-H3 抑制宫颈癌肿瘤进展。microRNAs 调控网络非常复杂。我们进一步研究了 microRNA-199a 对 AKT/mTOR 信号通路的影响。我们探讨了 microRNA-199a 的调节作用,并首次证明高表达的 microRNA-199a 通过靶向 B7-H3 抑制肿瘤生长并激活 AKT/mTOR 信号通路。我们的研究结果不仅提供了对宫颈癌发病机制的更好理解,而且为宫颈癌潜在的靶向治疗工具提供了新的发现和理论支持。